LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the launch ...

Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.

The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...

A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...